Valette (Combined Oral Contraceptive SH T04769G and SH D00659AF) Low Ovulation Inhibition

NCT00471991 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Oral Contraceptive

Interventions

DRUG: SH T04769G
DRUG: Ethinyl estradiol / dienogest (SH D00659 AF)

Sponsor

Bayer